When the TGF-β1 gene and protein expression increases in advanced disease stages, malignant progression is promoted by improving cancer cell survival, epithelial–mesenchymal transition (EMT), migration, invasion, and—ultimately—metastasis [36]. The gene discussed is TGFB1; the disease is cancer.